Results 31 to 40 of about 31,317 (345)

Subtle changes in striatal muscarinic M1 and M4 receptor expression in the DYT1 knock-in mouse model of dystonia.

open access: yesPLoS ONE, 2019
In early-onset generalized torsion dystonia, caused by a GAG deletion in TOR1A (DYT1), enhanced striatal cholinergic activity has been suggested to be critically involved. Previous studies have shown increased acetylcholine levels in the striatum of DYT1
Franziska Richter   +3 more
doaj   +1 more source

Unilateral mydriasis secondary to ipratropium bromide in a critically ill patient

open access: yesJournal of Emergencies, Trauma and Shock, 2012
Unilateral dilated pupil in a critical patient under sedation is an important clinical sign that requires prompt evaluation. An exhaustive assessment must be performed, including neurological examination and imaging tests, and pharmacological causes must
Luciano Santana-Cabrera   +4 more
doaj   +1 more source

Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin

open access: yesClinics, 2014
OBJECTIVES: Primary hyperhidrosis usually affects the hands, armpits, feet and cranio-facial region. Sweating in other areas is common in secondary hyperhidrosis (after surgery or in specific clinical conditions). Oxybutynin has provided good results and
Marcelo Passos Teivelis   +5 more
doaj   +1 more source

A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND: Cocaine increases the level of endogenous dopamine (DA) in the striatum by blocking the DA transporter. Endogenous DA modulates glutamatergic inputs to striatal neurons and this modulation influences motor activity.
Alessandro Tozzi   +14 more
doaj   +1 more source

Evaluation of Different Combined Regimens in the Treatment of Cholinergic Urticaria

open access: yesWorld Allergy Organization Journal, 2012
Background Cholinergic urticaria is uncommon and accounts for 10% of all young adults. To date, there is no effective therapy for cholinergic urticaria.Objective To determine the therapeutic efficacy of different drug combinations in the treatment of ...
Abdulghani M. Alsamarai, MD, PhD   +2 more
doaj   +1 more source

Inflammation Regulation via an Agonist and Antagonists of α7 Nicotinic Acetylcholine Receptors in RAW264.7 Macrophages

open access: yesMarine Drugs, 2022
The α7 nicotinic acetylcholine receptor (nAChR) is widely distributed in the central and peripheral nervous systems and is closely related to a variety of nervous system diseases and inflammatory responses.
Yao Tan   +5 more
doaj   +1 more source

Otorhinolaryngological adverse effects of urological drugs

open access: yesInternational Brazilian Journal of Urology, 2021
Purpose: To describe the otorhinolaryngological adverse effects of the main drugs used in urological practice. Materials and Methods: A review of the scientific literature was performed using a combination of specific descriptors (side effect, adverse ...
Nathalia de Paula Doyle Maia   +2 more
doaj   +1 more source

Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia

open access: yesNew England Journal of Medicine, 2021
The muscarinic receptor agonist xanomeline has antipsychotic properties and is devoid of dopamine receptor-blocking activity but causes cholinergic adverse events. Trospium is a peripherally restricted muscarinic receptor antagonist that reduces peripheral cholinergic effects of xanomeline. The efficacy and safety of combined xanomeline and trospium in
Brannan, Stephen K.   +5 more
openaire   +2 more sources

Basic and Clinical Aspects of Non-neuronal Acetylcholine: Expression of Non-neuronal Acetylcholine in Lung Cancer Provides a New Target for Cancer

open access: yesJournal of Pharmacological Sciences, 2008
Lung cancer is the leading cause of cancer death worldwide and new treatment strategies are clearly needed. The recent discovery that lung and other cancers synthesize and secrete acetylcholine (ACh) which acts as an autocrine growth factor suggests that
Therapy Pingfang Song, Eliot R. Spindel
doaj   +1 more source

An oral selective M3 cholinergic receptor antagonist in COPD [PDF]

open access: yesEuropean Respiratory Journal, 2006
Cholinergic antagonists have been used since the early 1900s as bronchodilators for chronic obstructive pulmonary disease (COPD). The present study investigated whether an oral muscarinic M3-selective anticholinergic agent (OrM3) would provide an improved therapeutic advantage compared with an inhaled anticholinergic agent in patients with COPD.A 6 ...
S, Lu   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy